However, plasma apoCIII had a moderate correlation with TG in non-CHD, CHD and statin treated CHD patients (r = 0.50, 0.59 and 0.58 respectively, p < 0.001); and HDL-apoCIII significantly correlated to plasma apoCIII regardless of whether statin drugs were used or not (r = 0.35, 0.31 and 0.35 respectively, p < 0.05). The gene discussed is APOC3; the disease is coronary artery disorder.